Doctor Robert Sepp
University of Szeged, Szeged (Hungary)
Follow
Contributor content
Presentation
Real-world data on the use of mavacamten in obstructive hypertrophic cardiomyopathy: one-year data from the multicentre MARVEL.HU study involving 133 patients
Presentation
Atrial fibrillation during mavacamten treatment in obstructive hypertrophic cardiomyopathy in the real-world: data from the multicenter MARVEL.HU registry on 133 patients
Presentation
Development of case definition criteria for querying insurance databases in heart failure epidemiological investigations: rationale and design of the HF-EPI-HUN study
Presentation
Effectiveness and safety of mavacamten in obstructive hypertrophic cardiomyopathy in the real world: one-year data from the multicentre MARVEL.HU study
Presentation
Prevalence and incidence of heart failure in Hungary stratified by age and sex: data from the Hungarian nationwide epidemiological study (HF-EPI-HUN) over a 15-year period (2009-2023)
Presentation
The epidemiology of heart failure in Hungary: basic data and temporal trends from the Hungarian nationwide epidemiological study (HF-EPI-HUN) over a 15-year period (2009-2023)
Presentation
Presentation
Decrease of ECG hypertrophy indices during mavacamten treatment in obstructive hypertrophic cardiomyopathy
Presentation
Reduction of >100 mmHg left ventricular outflow tract gradients in obstructive hypertrophic cardiomyopathy during mavacamten treatment already after one week of treatment
Presentation
